← Sunday Data · Cycle 7 · Week 8

The Independent Artist... Or Not

A few issues ago, I wrote about the perils of record labels (venture capital) and the appeal of being an independent artist (bootstrapped company).

For those who missed this issue, I argued that record labels and venture capital can strip up to 80% of ownership and profits from rising talent, and often get in the way of true artistry. My example rested on a personal anecdote: an old friend who starred on American Idol and spent most of her 20s fighting lawsuits with record labels. She came away from the experience too bruised to sing again (sad for us; she has a great voice and style).

For many braindrop trust circle recipients, this analogy resonated, particularly for entrepreneurs who felt finally seen as artists and creators. Rage against the businessman! It didn’t resonate as much with venture capitalists and record label owners. They felt that the resources they provided to the artists and entrepreneurs provided them with the chance of life vs death. Plus, I got the feeling the VCs and record labels felt they got little thanks for the lifelines they provided to creators.

Recently, I was asked why I am applying to Y Combinator and a16z SpeedRun, given my idealisation of the independent artist and bootstrapped company. It is a good question, and one I can answer. Let me begin by stating why I wrote the independent artist piece.

I feel that, in entrepreneurship circles, too much success is defined by venture capital raises. It is similar to the pressure artists feel to be signed by a record label. There are VC name brands, headline dollar figures, and star collaborations. I have certainly felt the pressure. If my father and older sister hadn't knocked some sense into me about “old school entrepreneurship,” I probably wouldn't have woken up from this fever dream.

The “independent artist” exploration was a thought piece. It gave me a space to think about – what if? Why do we raise money? What do we use the money for? Are there other ways to do it without the headline raise? Really basic questions… but ultimately, ones that helped me better understand my own strengths and weaknesses. Answering them allowed me to pursue the “YC” path (or similar) with a lot more conviction.

The first and primary thing that venture capital provides is money. Money pays for staff, compute, and hardware. In short, resources and shells for humans and computers to eat.

Most software companies today only need to pay for the living costs of human lives now – and sorry to say, but any software founder raising over $5m pre-seed is either paying for business-class flights for their girlfriend, or unable to get people to care about the project without paying them. I know this is game-theoretically non-optimal for me to say this, but I am past mincing words.

Apart from food on the table and shelter for our core team, resources to build are among the least of our weaknesses. It makes little sense to raise venture capital on a purely financial basis.

The second thing some venture capital programmes or angel investors provide is networks, credibility and skill-specific training. This varies a lot too: some of these programmes are more about basic entrepreneurship training and idea/team formation (Founder’s First, Antler). Others lean towards credibility and deep network establishment (Y Combinator, A16Z SpeedRun, or other programmes that may be more industry-specific).

Money, networks and training can all be acquired over time – for anyone and anything. Venture capital comes in when there needs to be a little “magic” done to time. So the question every founder needs to ask themselves: what do I need most? A time shortcut to money, networks, credibility, or training?

I am firm in my belief that Braindrop is a business with the primary success factors of trust, entrenched networks, and a level of intercultural UI/UX design legendary enough to earn a place at the MoMA in thirty years' time. A successful launch (network) is location-dependent: the world epicenters of biotech and pharma are San Diego, Boston, NY, and London. While solid networks in biotech and pharma theoretically take years and years to develop, I firmly believe that none of our founding team needs to sit inside a biotech or pharma company for years to generate the networks and credibility needed for Braindrop to succeed.

Interestingly, being a self-described “fintech engineer” building “financial infrastructure for the biotech and pharma industry” in a room full of biotech and health tech professionals doesn’t result in instant ostracisation. The reaction I get to my introduction tends to be even better from those who have been in the biotech and pharma industry for decades, who welcome a breath of fresh air in the tools they use. I don’t get questions like “how long have you been in biotech?”, or “what do you know about pharma?” (These are questions I often get from non-bio people, ironically). Pharma industry titans are more interested in hearing about how different industries have been transformed by technology. Carta for angel investments. Stripe for e-commerce. Vanta for compliance. They want their industry to be transformed too.

These experiences have led me to believe–with enough conviction to use our precious time filling in silly YC web forms–that our biggest weaknesses right now are proximity to clients and industry transformer tools and networks; weaknesses that could benefit from a little time magic.

Proximity to clients means solid relocation to the US or, at the very least, Europe. Our team is proudly multicultural, and this is a huge strength for Braindrop’s vision and why I’m not afraid of a team of SF-native geniuses copying us.

Having an international team, however, also means we suffer from not having everyone in the same room, working morning to night to accelerate progress. I have strongly considered why we can’t spend 6pm to 10pm intensively working together in Tokyo or in New Zealand, where we have proven to be able to develop at remarkable pace in the past. Unfortunately, our team’s proximity to clients is integral to getting feedback loops where the beat doesn’t syncopate too much and then go completely out of time.

Our other weakness is industry credibility and networks. By this, I mean the stripes to show that we come from a breed of industry transformers, not industry specialists.

It means being trained by industry transformer specialists like those at YC, Sequoia, a16z, et al., who have extremely diverse networks and tools necessary to be industry transformers. Braindrop does not need white lab coats and lab rats; we need legal networks, compliance tools, VC networks, multicultural UX/UI networks, cybersecurity tools, and proximity to orgs like Stripe that monetised currency flows at scale. We are doing quite well on this front on our own, but I’m aware that a little concentrated boost, particularly in the US, could mean the difference between Braindrop getting noteworthy traction in three months vs. three years.

In the music business, there is the concept of a “distribution” label. Not a record label. A distribution label. Without getting into too much detail, if you are an artist that can deliver a product (album, singles, music videos) at production quality, the distribution label will handle the distribution and promotion of the material globally; it handles legal, royalty collection and management, and positioning for the right industry networks to pick it up (i.e., MTV, Grammys, etc.). The distribution label typically takes less than 20 percent of revenue produced by the artwork, and the artist expects the label to make up for this by getting sales that far exceed what they would without.

I’m fairly confident that Braindrop’s very strong team and personal network can get us to handing in a studio single in good time. Unfortunately for Braindrop, over 50% of the tracks on our dream album are about distribution and disruption. That’s why I’m willing to take a 20% knife to the heart to get the distribution label contracts signed.